FIM
EXAS

Freedom Investment Management’s Exact Sciences EXAS Stock Holding History

Freedom Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,185
Closed -$289K – 814
2024
Q1 		$289K Sell
4,185
-735
-15% -$46.5K 0.02% 620
2023
Q4 		$364K Sell
4,920
-148
-3% -$9.7K 0.03% 527
2023
Q3 		$346K Buy
5,068
+314
+7% +$26.6K 0.04% 452
2023
Q2 		$446K Buy
+4,754
New +$371K 0.05% 428
2017
Q4 		– Sell
-4,647
Closed -$219K – 1143
2017
Q3 		$219K Sell
4,647
-2,524
-35% -$102K 0.01% 981
2017
Q2 		$254K Sell
7,171
-1,350
-16% -$41.7K 0.01% 876
2017
Q1 		$201K Buy
+8,521
New +$169K 0.01% 963

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Freedom Investment Management's EXAS Position: Q2 2024 in Review

Freedom Investment Management sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 4,185 shares — an estimated $289K sold.

Freedom Investment Management first reported a position in EXAS in Q1 2017 and held it in 7 quarters. The position peaked at $446K in Q2 2023. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Freedom Investment Management reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Freedom Investment Management sold 4,185 Exact Sciences shares in Q2 2024, an estimated $289K.
  • Freedom Investment Management first reported a position in Exact Sciences in Q1 2017 and held it in 7 quarters.
  • Freedom Investment Management's Exact Sciences position peaked at $446K in Q2 2023.
  • 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Freedom Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.